Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-23-039827
Filing Date
2023-11-08
Accepted
2023-11-08 07:02:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13g.htm SC 13G 109620
  Complete submission text file 0001493152-23-039827.txt   110917
Mailing Address 101 EAST 52ND ST NEW YORK NY 10022
Business Address
HIRSCHMAN ORIN (Filed by) CIK: 0001131362 (see all company filings)

Type: SC 13G

Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Subject) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91306 | Film No.: 231385917
SIC: 2834 Pharmaceutical Preparations